Informações:
Falhas:
ID
23211
Descrição
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00602693
Link
https://clinicaltrials.gov/show/NCT00602693
Palavras-chave
Versões (1)
- 28/06/2017 28/06/2017 -
Transferido a
28 de junho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Leukemia NCT00602693
Eligibility Leukemia NCT00602693
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia NCT00602693
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
ages 18 to 75 years old
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
eligible for and co-enrolled on protocol umn-2005ls036, for treatment of any of the following advanced hematologic malignancies:
boolean
C2347180 (UMLS CUI [1])
ID.3
Item
acute leukemias in complete remission (high risk cr1 or subsequent cr); chronic myelogenous leukemia (except refractory blast crisis); myelodysplastic syndrome with severe pancytopenia or complex cytogenetics, large-cell lymphoma, hodgkin's lymphoma and multiple myeloma, chronic lymphocytic leukemia/small lymphocytic lymphoma, marginal zone b-cell lymphoma, follicular lymphoma, lymphoplasmacytic lymphoma, mantle-cell lymphoma, prolymphocytic leukemia may be eligible after initial therapy.
boolean
C0023418 (UMLS CUI [1,1])
C3463824 (UMLS CUI [1,2])
C0026764 (UMLS CUI [1,3])
C0024299 (UMLS CUI [1,4])
C3463824 (UMLS CUI [1,2])
C0026764 (UMLS CUI [1,3])
C0024299 (UMLS CUI [1,4])
ID.4
Item
have three partially hla matched umbilical cord blood (ucb) units (1-2 units for ucb transplantation per mt2005-02 and 1 unit for the treg cell infusion.)
boolean
C0019721 (UMLS CUI [1,1])
C0162371 (UMLS CUI [1,2])
C0162371 (UMLS CUI [1,2])
ID.5
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
ID.6
Item
patients not exposed to highly immunosuppressive single agent or multi-agent chemotherapy within 3 months, or an ablative preparative regimen for autologous hematopoietic stem cell transplant (hct) within 1 year.
boolean
C0021081 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0472699 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,2])
C0472699 (UMLS CUI [1,3])
ID.7
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
ID.8
Item
current active serious infection
boolean
C3714514 (UMLS CUI [1])
ID.9
Item
evidence of human immunodeficiency virus (hiv) or known hiv positive serology
boolean
C0019682 (UMLS CUI [1])
ID.10
Item
patients with acute leukemia in morphologic relapse/persistent disease defined as >5% blasts in a > or = 15% cellular bone marrow or any % blasts if blasts have unique morphologic markers (e.g., auer rods) or associated cytogenetic markers that allows morphologic relapse to be distinguished are not eligible.
boolean
C2367453 (UMLS CUI [1])
ID.11
Item
chronic myelogenous leukemia in refractory blast crisis.
boolean
C1370868 (UMLS CUI [1,1])
C0919644 (UMLS CUI [1,2])
C0919644 (UMLS CUI [1,2])
ID.12
Item
active central nervous system malignancy.
boolean
C0085136 (UMLS CUI [1])